KAIROS: A non-interventional study of ofatumumab in patients with relapsing remitting multiple sclerosis who previously received another disease-modifying therapy

被引：0
|
作者：
Bischof, Felix [1 ]
Groth, Marie [2 ]
Redolfi, Josef [2 ]
机构：
[1] Medicum Gesundheitszentrum, Neurol & Psychiat, Boblingen, Germany
[2] Novartis Pharma Vertriebs GmbH, Nurnberg, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1590/570
引用
收藏
页码：1013 / 1013
页数：1
相关论文
共 50 条
  • [1] KAIROS: Real world evidence of ofatumumab in patients with relapsing remitting multiple sclerosis who previously received another disease-modifying therapy
    Bischof, Felix
    Groth, Marie
    Redolfi, Josef
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1102 - 1102
  • [2] The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective Study
    Lenz, Florian
    Harms, Lutz
    ADVANCES IN THERAPY, 2020, 37 (06) : 2999 - 3009
  • [3] The Impact of Patient Support Programs on Adherence to Disease-Modifying Therapies of Patients with Relapsing-Remitting Multiple Sclerosis in Germany: A Non-Interventional, Prospective Study
    Florian Lenz
    Lutz Harms
    Advances in Therapy, 2020, 37 : 2999 - 3009
  • [4] Disease-modifying therapy in adult relapsing-remitting multiple sclerosis
    Rosenzweig, Tamara M.
    Hartman, Sarah
    MacKenzie, Elizabeth
    FORMULARY, 2010, 45 (08) : 252 - 262
  • [5] Discontinuation of Disease-Modifying Therapy for Patient with Relapsing-Remitting Multiple Sclerosis
    Yano, Hajime
    Gonzalez, Cindy T.
    Healy, Brian C.
    Glanz, Bonnie I.
    Weiner, Howard L.
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 47 - 47
  • [6] Disease-modifying therapy in relapsing-remitting multiple sclerosis: efficacy is paramount
    Cristiano, E
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 3 - 7
  • [7] Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis
    Parks, Natalie E.
    Andreou, Pantelis
    Marrie, Ruth Ann
    Fisk, John
    Bhan, Virender
    Kirkland, Susan A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [8] Disease-modifying effect of circuit class therapy in patients with relapsing-remitting multiple sclerosis
    Kolcava, J.
    Vlckova, E.
    Kocica, J.
    Sladeckova, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 395 - 396
  • [9] Disease-modifying therapies in relapsing-remitting multiple sclerosis
    Gonzalez-Andrade, Fabricio
    Luis Alcaraz-Alvarez, Jose
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 365 - 373
  • [10] Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
    Roos, Izanne
    Malpas, Charles
    Leray, Emmanuelle
    Casey, Romain
    Horakova, Dana
    Havrdova, Eva Kubala
    Debouverie, Marc
    Patti, Francesco
    De Seze, Jerome
    Izquierdo, Guillermo
    Eichau, Sara
    Edan, Gilles
    Prat, Alexandre
    Girard, Marc
    Ozakbas, Serkan
    Grammond, Pierre
    Zephir, Helene
    Ciron, Jonathan
    Maillart, Elisabeth
    Moreau, Thibault
    Amato, Maria Pia
    Labauge, Pierre
    Alroughani, Raed
    Buzzard, Katherine
    Skibina, Olga
    Terzi, Murat
    Laplaud, David Axel
    Berger, Eric
    Grand'Maison, Francois
    Lebrun-Frenay, Christine
    Cartechini, Elisabetta
    Boz, Cavit
    Lechner-Scott, Jeannette
    Clavelou, Pierre
    Stankoff, Bruno
    Prevost, Julie
    Kappos, Ludwig
    Pelletier, Jean
    Shaygannejad, Vahid
    Yamout, Bassem, I
    Khoury, Samia J.
    Gerlach, Oliver
    Spitaleri, Daniele L. A.
    Van Pesch, Vincent
    Gout, Olivier
    Turkoglu, Recai
    Heinzlef, Olivier
    Thouvenot, Eric
    McCombe, Pamela Ann
    Soysal, Aysun
    NEUROLOGY, 2022, 99 (17) : E1926 - E1944
12345